About
Onco Response is a clinical-stage biotechnology company developing personalized T cell receptor-engineered therapies designed to target cancer antigens in solid tumors.
Explore Onco Response's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.